DE2232827A1 - Neue steroide und verfahren zu ihrer herstellung - Google Patents
Neue steroide und verfahren zu ihrer herstellungInfo
- Publication number
- DE2232827A1 DE2232827A1 DE2232827A DE2232827A DE2232827A1 DE 2232827 A1 DE2232827 A1 DE 2232827A1 DE 2232827 A DE2232827 A DE 2232827A DE 2232827 A DE2232827 A DE 2232827A DE 2232827 A1 DE2232827 A1 DE 2232827A1
- Authority
- DE
- Germany
- Prior art keywords
- adamantane
- compound
- salt
- carboxylic acid
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3134971A GB1391443A (en) | 1971-07-05 | 1971-07-05 | Ester of betamethasone and its 9alpha-chloro analogue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2232827A1 true DE2232827A1 (de) | 1973-01-18 |
Family
ID=10321802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2232827A Ceased DE2232827A1 (de) | 1971-07-05 | 1972-07-04 | Neue steroide und verfahren zu ihrer herstellung |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS5644079B1 (enExample) |
| AR (2) | AR194120A1 (enExample) |
| AU (1) | AU464251B2 (enExample) |
| BE (1) | BE785812A (enExample) |
| CA (1) | CA983919A (enExample) |
| CH (1) | CH609065A5 (enExample) |
| DE (1) | DE2232827A1 (enExample) |
| DK (1) | DK131474B (enExample) |
| FR (1) | FR2144761B1 (enExample) |
| GB (1) | GB1391443A (enExample) |
| IE (1) | IE36529B1 (enExample) |
| IL (1) | IL39821A (enExample) |
| NL (1) | NL169882C (enExample) |
| NO (1) | NO137754C (enExample) |
| PH (1) | PH13195A (enExample) |
| SE (1) | SE385904B (enExample) |
| ZA (1) | ZA724598B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2512915A1 (de) * | 1974-03-27 | 1975-10-09 | Plurichemie Anstalt | 16-methyl-9 alpha-halogen-steroide ester, aether und verfahren zu ihrer herstellung |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS49116217A (enExample) * | 1973-01-03 | 1974-11-06 | ||
| JPS6163976U (enExample) * | 1984-10-01 | 1986-05-01 | ||
| PT2805720T (pt) | 2008-05-28 | 2019-09-23 | Reveragen Biopharma Inc | Moduladores esteroides não hormonais de nf-kb para tratamento de uma doença |
| EP2556083A4 (en) | 2010-04-05 | 2013-12-04 | Validus Biopharma Inc | NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT |
| US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
| US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
-
0
- BE BE785812D patent/BE785812A/xx not_active IP Right Cessation
-
1971
- 1971-07-05 GB GB3134971A patent/GB1391443A/en not_active Expired
-
1972
- 1972-07-04 ZA ZA724598A patent/ZA724598B/xx unknown
- 1972-07-04 NL NLAANVRAGE7209345,A patent/NL169882C/xx not_active IP Right Cessation
- 1972-07-04 AR AR242889A patent/AR194120A1/es active
- 1972-07-04 CA CA146,248A patent/CA983919A/en not_active Expired
- 1972-07-04 AU AU44205/72A patent/AU464251B2/en not_active Expired
- 1972-07-04 CH CH1003472A patent/CH609065A5/xx not_active IP Right Cessation
- 1972-07-04 DK DK331372AA patent/DK131474B/da unknown
- 1972-07-04 DE DE2232827A patent/DE2232827A1/de not_active Ceased
- 1972-07-04 FR FR7224132A patent/FR2144761B1/fr not_active Expired
- 1972-07-04 JP JP6640472A patent/JPS5644079B1/ja active Pending
- 1972-07-04 IL IL39821A patent/IL39821A/xx unknown
- 1972-07-04 IE IE939/72A patent/IE36529B1/xx unknown
- 1972-07-04 SE SE7208817A patent/SE385904B/xx unknown
- 1972-07-04 NO NO2406/72A patent/NO137754C/no unknown
- 1972-07-05 PH PH13687A patent/PH13195A/en unknown
-
1973
- 1973-05-21 AR AR248131A patent/AR194553A1/es active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2512915A1 (de) * | 1974-03-27 | 1975-10-09 | Plurichemie Anstalt | 16-methyl-9 alpha-halogen-steroide ester, aether und verfahren zu ihrer herstellung |
Also Published As
| Publication number | Publication date |
|---|---|
| NL169882B (nl) | 1982-04-01 |
| NO137754B (no) | 1978-01-09 |
| IL39821A0 (en) | 1972-09-28 |
| CH609065A5 (en) | 1979-02-15 |
| CA983919A (en) | 1976-02-17 |
| PH13195A (en) | 1980-01-18 |
| NL7209345A (enExample) | 1973-01-09 |
| DK131474B (da) | 1975-07-21 |
| GB1391443A (en) | 1975-04-23 |
| AR194120A1 (es) | 1973-06-22 |
| FR2144761B1 (enExample) | 1976-03-05 |
| DK131474C (enExample) | 1975-12-08 |
| AR194553A1 (es) | 1973-07-23 |
| NO137754C (no) | 1978-04-19 |
| IE36529L (en) | 1973-01-05 |
| IE36529B1 (en) | 1976-11-24 |
| BE785812A (fr) | 1973-01-04 |
| JPS5644079B1 (enExample) | 1981-10-16 |
| FR2144761A1 (enExample) | 1973-02-16 |
| ZA724598B (en) | 1973-03-28 |
| AU464251B2 (en) | 1975-08-21 |
| IL39821A (en) | 1976-02-29 |
| NL169882C (nl) | 1982-09-01 |
| AU4420572A (en) | 1974-01-10 |
| SE385904B (sv) | 1976-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69720996T2 (de) | Neue pharmazeutische zusammensetzungen von steroid-nitratester zur verwendung als enzündungshemmer | |
| DE2222491C3 (de) | Steroid-21-salpetersäureester der Pregnanreihe, solche enthaltende Arzneimittel und Verfahren zur Herstellung derselben | |
| DE68910211T2 (de) | Estramustin-ester. | |
| DE2232827A1 (de) | Neue steroide und verfahren zu ihrer herstellung | |
| DE1951790C3 (de) | In 17-StelIung veresterte Steroid-21-phosphate der Pregnanreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Zubereitungen | |
| DE69306303T2 (de) | Monoquaternäre 2,16-Bispiperidinglandrostanderivate | |
| DE2323744C3 (de) | 4,4'-Bismethylen-(3-methoxy-2-naphthoesäure-triamcinolon-acetonidester) und Verfahren zu dessen Herstellung | |
| EP0100516A2 (de) | 3-Beta-(3'-(Carboxypropionyloxy))-ursa-9(11),12-dien-28-carbonsäure sowie ihre Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE1643033B2 (de) | 9 alpha, 11 beta-dichlor-16 alpha- methyl-1,4-pregnadien-17 alpha, 21-diol- 3,20-dion-17-ester verfahren zu ihrer herstellung und sie enthaltende therapeutische zubereitungen | |
| DE69518258T2 (de) | Kortikoidderivate und pharmazeutische und kosmetische Zusammensetzungen | |
| DE1934392C3 (de) | Neue 2-Pyridylthioamide und Verfahren zu ihrer Herstellung | |
| DE2337882C3 (de) | Bis-Piperazino-Androstan-Derivate und Verfahren zu ihrer Herstellung | |
| DE2162592A1 (de) | Steroide der 5 alpha-Pregnan-Reihen | |
| EP0313935A2 (de) | Enolether von 6-Chlor-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carbonsäureamid-1,1-dioxid, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung | |
| DE3116891A1 (de) | Steroid-oxazole | |
| DE2300166A1 (de) | Neue steroidverbindungen und verfahren zu ihrer herstellung | |
| CH597256A5 (en) | Dexamethasone 21-adamantoate | |
| CH526526A (de) | Verfahren zur Herstellung eines neuen 6a-Methyl-19-nor-progesterons | |
| DE2031205C3 (de) | Verfahren zur Herstellung von 17-Monoestern von 17 alpha, 21-Dihydroxy-20-ketosteroiden und Prednisolon-17benzoat | |
| DE1922126C3 (de) | 6,17-Dichlor-A4'6 -pregnadiene, Verfahren zu deren Herstellung, diese enthaltende Arzneimittel sowie | |
| DE1468681C3 (de) | 17beta-Tetrahydropyranyloxy verbindungen der Androstanreihe sowie Verfahren zu ihrer Herstellung und Heilmittel | |
| AT361644B (de) | Verfahren zur herstellung von neuen d-homosteroiden | |
| DE2152001C3 (de) | 3-Piperidino- und 3-Morpholinopropylbenzoate und deren Salze, Verfahren zur Herstellung derselben sowie solche Verbindungen enthaltende Arzneimittel | |
| DE1418320C (de) | Verfahren zur Herstellung von 16 alpha-Methyl- 1,4-pregnadien-17 alpha, 21-diol-3,11,20-trion und von entsprechenden 21niedermolekularen Alkansäureestern desselben | |
| DE1493313C (de) | 16b, 17 Cycloenolather des 17alpha Hydroxy öalpha methyl 3,20 dioxo 4 pregnen 16alpha acetaldehyds und des 1 lbeta, 17alpha Dihydroxy 9alpha fluor 6alpha methyl 3,20 dioxo 1,4 pregnadien 16alpha acetaldehyds und Verfahren zu ihrer Herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OD | Request for examination | ||
| 8131 | Rejection |